CME Group Inc. $CME Shares Newly Bought by Montrusco Bolton Investments Inc.

Montrusco Bolton Investments Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the third quarter, Holdings Channel.com reports. The firm bought 289,492 shares of the financial services provider’s stock, valued at approximately $75,841,000. CME Group accounts for approximately 1.2% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 25th largest holding.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of CME Group in the second quarter valued at approximately $6,749,965,000. Bank of New York Mellon Corp acquired a new position in CME Group during the 2nd quarter worth $867,313,000. Alphabet Inc. acquired a new position in CME Group during the 2nd quarter worth $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in CME Group during the 2nd quarter worth $629,771,000. Finally, Bank of America Corp DE bought a new position in CME Group in the 2nd quarter valued at $622,679,000. 87.75% of the stock is owned by institutional investors.

CME Group Trading Up 0.3%

NASDAQ CME traded up $0.79 during trading hours on Tuesday, hitting $278.03. The company’s stock had a trading volume of 1,418,779 shares, compared to its average volume of 2,522,823. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The firm has a market capitalization of $99.97 billion, a P/E ratio of 23.58, a PEG ratio of 3.67 and a beta of 0.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a fifty day moving average of $272.29 and a 200 day moving average of $270.83.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.96 EPS. Equities research analysts forecast that CME Group Inc. will post 12.29 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CME shares. Barclays lifted their target price on CME Group from $270.00 to $281.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 7th. Morgan Stanley upped their price target on CME Group from $330.00 to $337.00 and gave the company an “overweight” rating in a research note on Friday. Bank of America upped their price target on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target on the stock in a report on Thursday, June 18th. Finally, Piper Sandler lowered their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $292.06.

Insider Transactions at CME Group

In related news, Director Elizabeth A. Cook sold 500 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the completion of the sale, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 15,000 shares of the stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the transaction, the chief executive officer directly owned 40,630 shares in the company, valued at $11,150,497.20. The trade was a 26.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.